Form D · Biotechnology
Focal Medical, Inc.
Cary, NC · CIK 0001831601
Offering snapshot reported Mar 4, 2024 · SEC filing
- Reported sold
- $950K Offering amount: $950K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 21, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 4, 2024 | Initial | $950,000 | No comparison | 2 | SEC filing |
| Nov 6, 2020 | Initial | $5,499,993 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-506572
Source: Form D, filed Mar 4, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Aldridge | Director, Executive |
| Nessan Bermingham | Director |
| Joseph De Simone | Director |
| Anthony S. Voiers | Director, Executive, Promoter |
| Jen Jen Yeh | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
111 James Jackson Avenue Suite 131
Cary, NC, 27513
Cary, NC, 27513